FDA approves cardiac ablation products from St Jude.
Interventional Cardiology
Abbott Sales Figures For Xience Stents Confirm Market Leadership According To Company
Abbott is sounding very pleased with itself about its drug-eluting stent sales figures, which it claims confirms its status as global market leader.
Patient Data From ICDs: Makes Sense Even For Non-Geeks.
The campaign to make data from remote monitoring devices available to patients gathers pace.
CE Mark And Launch For Sorin’s New Pacing, Defibrillation And Left Ventricular Leads
New lead portfolio combined with Sorin Group’s innovative and intelligent devices provide full-featured systems for accurate management of arrhythmias and heart failure
Would You Want To See Real-Time Data from Your Implantable Pacemaker?
Access to one’s own real-time heart function data. Might it frighten us to death?
Just A Reminder: SJM Riata Is Subject To Alert In UK Too
Details of UK MHRA’s alert relating to St Jude’s Riata defibrillator leads.
CE Mark For “Bi-Directional Retrieval” Inferior Vena Cava Filter
Crux Biomedical has announced it has received CE mark approval for its revolutionary inferior vena cava filter with bi-directional retrieval.
CoreValve US Trial: Extreme Risk Group Enrollment Complete.
Medtronic gets a little closer to market (in USA) with the announcement that CoreValve’s extreme risk group enrollment is now complete.
Sparks Fly At Riata Lead Summit
A sizeable group of clinicians and St Jude representatives have met to discuss the issue of “externalised” Riata implantable defibrillator leads.
“Which Medical Device?” Announces Winners
Which Medical Device (whichmedicaldevice.com) has announced the winners of its “Device of the Year” awards, based on assessment of reader feedback by the expert judging panel.
EVEREST II Study: MitraClip “May” Be Justified In High-Surgical-Risk Patients.
Results from “high-surgical-risk” study arm of MitraClip EVEREST II trial suggest the device does provide limited reduction in mitral regurgitation in patients for whom surgery is not an option.
Real-world Post-AF Ablation Data From 4000 Cases
Heartwire (theheart.org) has reported on a study summarising “real-world” experiences with AF Ablation and found patient factors and hospital procedure volume to be determinants of post-operative complications and rehospitalisation.
St. Jude Completes Enrollment In “RESPECT” PFO Occlusion Trial.
St. Jude Medical, Inc. has announced that it has met a stopping rule in its RESPECT clinical trial and is closing patient enrollment. The company expects to present its findings during 2012.
Study Shows Home Monitoring Of Pacemaker Patients Advances Treatment And Reduces Burden On Clinics.
First large-scale pacemaker study shows significant reduction in hospitalisations for atrial arrhythmias and related stroke with BIOTRONIK Home Monitoring®
CE Mark For Robotic Catheter Guidance Control and Imaging™System .
California-based Magnetecs Corporation has reported that the company’s Robotic Catheter Guidance Control and Imaging™ (CGCI) System has received CE Marking certification.
Angio-Seal Disputes: Kensey Nash And St. Jude Medical Agree To Mediation
Kensey Nash Corporation and St. Jude Medical will enter into non-binding mediation in an attempt to resolve disputes over royalty payments to Kensey Nash relating to the Angio-Seal vascular closure device, as well as other related claims.